Clincosm LogoSign in Get a demo

advanced breast cancer

Showing 26 - 50 of 149
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Unraveling KAdcyla Resistance In Human Epidermal Growth Factor

Completed
  • Advanced Breast Cancer
    • Sevilla, Andalucía, Spain
    • +9 more
    Jan 12, 2023

    Advanced Breast Cancer Trial in Spain (Olaparib)

    Completed
    • Advanced Breast Cancer
    • Badalona, Barcelona, Spain
    • +15 more
    Jan 12, 2023

    Advanced Breast Cancer Trial in Spain (Pembrolizumab, Gemcitabine)

    Completed
    Has Results
    • Advanced Breast Cancer
    • Badalona, Barcelona, Spain
    • +8 more
    Apr 12, 2022

    Breast Tumor, Breast Cancer, Hormone Receptor Positive Tumor Trial in Shanghai (PIK3CA inhibitor, AKT inhibitor, Carrelizumab)

    Recruiting
    • Breast Neoplasm
    • +4 more
    • PIK3CA inhibitor
    • +12 more
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jan 2, 2023

    Solid Tumor, Advanced Breast Cancer Trial in Milwaukee (Abemaciclib, Hydroxychloroquine 200 mg, Faslodex)

    Withdrawn
    • Solid Tumor
    • Advanced Breast Cancer
    • Milwaukee, Wisconsin
      Froedtert Hospital and the Medical College of Wisconsin
    Dec 21, 2022

    Breast Cancer, Treatment Side Effects, Advanced Breast Cancer Trial in Shanghai (Tumor Infiltrating Lymphocytes (TIL))

    Recruiting
    • Breast Cancer
    • +3 more
    • Tumor Infiltrating Lymphocytes (TIL)
    • Shanghai, China
      Shanghai Tenth People's Hospital
    Dec 19, 2022

    Advanced Breast Cancer Trial in Moldova, Republic of, United States (Lerociclib + Letrozole or Fulvestrant)

    Recruiting
    • Advanced Breast Cancer
    • Lerociclib + Letrozole or Fulvestrant
    • Jacksonville, Florida
    • +16 more
    Dec 15, 2022

    Carcinoma, Ductal, Breast, Breast Cancer Female, Breast Tumor Trial in Worldwide (G1T48, Palbociclib)

    Completed
    • Carcinoma, Ductal, Breast
    • +6 more
    • Beverly Hills, California
    • +14 more
    Dec 14, 2022

    Advanced Breast Cancer Trial in Thalassery (Alpelisib, Fulvestrant)

    Recruiting
    • Advanced Breast Cancer
    • Thalassery, Kerala, India
      Novartis Investigative Site
    Nov 21, 2022

    Advanced Breast Cancer Trial in Orebro (Alpelisib, fulvestrant)

    Terminated
    • Advanced Breast Cancer
    • Orebro, Sweden
    • +1 more
    Nov 21, 2022

    Advanced Head and Neck Squamous Cell Carcinoma, Advanced Breast Cancer, Advanced Melanoma Trial in Worldwide (CyPep-1,

    Not yet recruiting
    • Advanced Head and Neck Squamous Cell Carcinoma
    • +2 more
    • CyPep-1
    • Pembrolizumab 25 MG/ML [Keytruda]
    • Pittsburgh, Pennsylvania
    • +18 more
    Nov 21, 2022

    Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

    Active, not recruiting
    • Advanced Breast Cancer
    • +2 more
    • Talazoparib Tosylate
    • Stanford, California
      Stanford University Hospitals and Clinics
    Nov 16, 2022

    Breast Cancer, Advanced Breast Cancer Trial in Stanford (Talazoparib Tosylate)

    Not yet recruiting
    • Breast Cancer
    • Advanced Breast Cancer
    • Talazoparib Tosylate
    • Stanford, California
      Stanford University
    Nov 9, 2022

    Brain Metastases, Human Epidermal Growth Factor 2 Positive Carcinoma of Breast, Advanced Breast Cancer Trial (Trastuzumab,

    Recruiting
    • Brain Metastases
    • +2 more
    • Saint Louis, Missouri
    • +1 more
    Nov 8, 2022

    HER2-negative Breast Cancer, Advanced Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in India, United States (Part

    Recruiting
    • HER2-negative Breast Cancer
    • +2 more
    • Part 1
    • +2 more
    • Los Angeles, California
    • +11 more
    Oct 29, 2022

    Palbociclib in Real World Practice

    Recruiting
    • Advanced Breast Cancer
    • Metastatic Breast Cancer
    • non-interventional
    • Alabaster, Alabama
    • +304 more
    Oct 10, 2022

    Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

    Terminated
    • Glioma
    • +23 more
    • Tucson, Arizona
    • +11 more
    Sep 30, 2022

    Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)

    Not yet recruiting
    • Advanced Breast Cancer
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Sep 12, 2022

    Metastatic Breast Cancer, Advanced Breast Cancer, HR-positive Breast Cancer Trial (OP-1250, Ribociclib, Alpelisib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • +3 more
    • (no location specified)
    Aug 18, 2022

    Breast Cancer, Breast Tumors, Breast Tumor Female Trial in Germany (Ribociclib)

    Not yet recruiting
    • Breast Cancer
    • +6 more
    • Erlangen, Bavaria, Germany
    • +15 more
    Aug 10, 2022

    Advanced Breast Cancer Trial in Worldwide (Trastuzumab, Alpelisib, Fulvestrant)

    Recruiting
    • Advanced Breast Cancer
    • Trastuzumab
    • +5 more
    • Graz, Austria
    • +107 more
    Aug 8, 2022

    Advanced Breast Cancer Trial in Worldwide (Ribociclib, fulvestrant, Ribociclib )

    Active, not recruiting
    Has Results
    • Advanced Breast Cancer
    • Mobile, Alabama
    • +173 more
    Aug 4, 2022

    2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2-

    Recruiting
    • Advanced Breast Cancer
    • +2 more
      • Ancona, Italy
      • +28 more
      Jul 27, 2022

      Advanced Solid Tumor, Advanced Breast Cancer, Advanced Gastric Cancer Trial in Boston, Dallas, Fairfax (IMM2902)

      Recruiting
      • Advanced Solid Tumor
      • +2 more
      • Boston, Massachusetts
      • +2 more
      Jul 21, 2022

      Advanced Breast Cancer Trial (Dalpiciclib+ letrozole +capecitabine)

      Not yet recruiting
      • Advanced Breast Cancer
      • Dalpiciclib+ letrozole +capecitabine
      • (no location specified)
      Jul 21, 2022